Ranitidine
NDC 55111-131, Ranitidine, tablet, from Dr. Reddy's Laboratories Limited.
- Product NDC
- 55111-131
- Status
- Listed
- Labeler
- Dr. Reddy's Laboratories Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA075294
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55111-131 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RANITIDINE HYDROCHLORIDE75 mg/1
Pharmacologic classes
Histamine H2 Receptor Antagonists [MoA]; Histamine-2 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55111-131-04 | 55111013104 | 1 BOTTLE in 1 CARTON (55111-131-04) / 120 TABLET in 1 BOTTLE |
| 55111-131-14 | 55111013114 | 2 BLISTER PACK in 1 CARTON (55111-131-14) / 10 TABLET in 1 BLISTER PACK |
| 55111-131-30 | 55111013130 | 1 BOTTLE in 1 CARTON (55111-131-30) / 30 TABLET in 1 BOTTLE |
| 55111-131-37 | 55111013137 | 1 BOTTLE in 1 CARTON (55111-131-37) / 160 TABLET in 1 BOTTLE |
| 55111-131-45 | 55111013145 | 1 BOTTLE in 1 CARTON (55111-131-45) / 45 TABLET in 1 BOTTLE |
| 55111-131-60 | 55111013160 | 1 BOTTLE in 1 CARTON (55111-131-60) / 60 TABLET in 1 BOTTLE |
| 55111-131-79 | 55111013179 | 1 BLISTER PACK in 1 CARTON (55111-131-79) / 10 TABLET in 1 BLISTER PACK |
| 55111-131-80 | 55111013180 | 1 BOTTLE in 1 CARTON (55111-131-80) / 80 TABLET in 1 BOTTLE |
| 55111-131-81 | 55111013181 | 3 BLISTER PACK in 1 CARTON (55111-131-81) / 10 TABLET in 1 BLISTER PACK |
| 55111-131-90 | 55111013190 | 1 BOTTLE in 1 CARTON (55111-131-90) / 90 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 55111-131 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55111-131 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55111-131. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.